- Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
[作者:Chawla, SP; Staddon, AP; Baker, LH; Schuetze, SM; Tolcher, AW; D'Amato, GZ; Blay, JY; Mita, MM; Sankhala, KK; Berk, L; Rivera, VM; Clackson, T; Loewy, JW; Haluska, FG; Demetri, GD,期刊:Journal of clinical oncology, 页码:78-84 , 文章类型: Article,,卷期:2012年30-1]
- Purpose Ridaforolimus is an inhibitor of mammalian target of rapamycin, an integral component of the phosphatidyl 3-kinase/AKT signaling pathway, with early evidence of activity in sarcomas. This multicenter, open-label,...
- Impact of Body Mass Index on Survival After Colorectal Cancer Diagnosis: The Cancer Prevention Study-II Nutrition Cohort
[作者:Campbell, PT; Newton, CC; Dehal, AN; Jacobs, EJ; Patel, AV; Gapstur, SM,期刊:Journal of clinical oncology, 页码:42-52 , 文章类型: Article,,卷期:2012年30-1]
- Purpose The impact of body mass index (BMI) on survival after colorectal cancer diagnosis is poorly understood. This study assessed the association of pre- and postdiagnosis BMI with all-cause and cause-specific survival...
- Impact of Diabetes Mellitus and Insulin Use on Survival After Colorectal Cancer Diagnosis: The Cancer Prevention Study-II Nutrition Cohort
[作者:Dehal, AN; Newton, CC; Jacobs, EJ; Patel, AV; Gapstur, SM; Campbell, PT,期刊:Journal of clinical oncology, 页码:53-59 , 文章类型: Article,,卷期:2012年30-1]
- Purpose To examine the association between type 2 diabetes mellitus (T2DM) and survival among patients with colorectal cancer (CRC) and to evaluate whether this association varies by sex, insulin treatment, and durations...
- Clinical Cancer Advances 2011: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
[作者:Vogelzang, NJ; Benowitz, SI; Adams, S; Aghajanian, C; Chang, SM; Dreyer, ZE; Janne, PA; Ko, AH; Masters, GA; Odenike, O; Patel, JD; Roth, BJ; Samlowski, WE; Seidman, AD; Tap, WD; Temel, JS; Von Roenn, JH; Kris, MG,期刊:Journal of clinical oncology, 页码:88-109 , 文章类型: Article,,卷期:2012年30-1]
-
- Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell Transplantation
[作者:Khera, N; Storer, B; Flowers, MED; Carpenter, PA; Inamoto, Y; Sandmaier, BM; Martin, PJ; Lee, SJ,期刊:Journal of clinical oncology, 页码:71-77 , 文章类型: Article,,卷期:2012年30-1]
- Purpose Our objective was to describe the incidence of nonmalignant late complications and their association with health and functional status in a recent cohort of hematopoietic cell transplantation (HCT) survivors. Pat...
- Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
[作者:Joensuu, H; Kellokumpu-Lehtinen, PL; Huovinen, R; Jukkola-Vuorinen, A; Tanner, M; Kokko, R; Ahlgren, J; Auvinen, P; Paija, O; Helle, L; Villman, K; Nyandoto, P; Nilsson, G; Pajunen, M; Asola, R; Poikonen, P; Leinonen, M; Kataja, V; Bono, P; Lindman, H,期刊:Journal of clinical oncology, 页码:11-18 , 文章类型: Article; Proceedings Paper,,卷期:2012年30-1]
- Purpose Capecitabine is an active agent in the treatment of breast cancer. It is not known whether integration of capecitabine into an adjuvant regimen that contains a taxane, an anthracycline, and cyclophosphamide impro...
- Molecular Detection of Tumor Cells in Regional Lymph Nodes Is Associated With Disease Recurrence and Poor Survival in Node-Negative Colorectal Cancer: A Systematic Review and Meta-Analysis
[作者:Rahbari, NN; Bork, U; Motschall, E; Thorlund, K; Buchler, MW; Koch, M; Weitz, J,期刊:Journal of clinical oncology, 页码:60-70 , 文章类型: Article,,卷期:2012年30-1]
- Purpose Up to 25% of patients with node-negative colorectal cancer (CRC) on conventional histopathologic analysis ultimately die of recurrent disease. We performed a systematic review with meta-analyses to clarify whethe...
|